Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-015381-64Phase 4Completed
Phase 4, single-arm trial of levocetirizine in allergic rhinitis (AR), sponsored by Clinical Research International. Primary endpoints: Visualization of effect on nasal cavity dimensions and 24-hour profile of anti-obstructive action. Started Oct 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-015381-64.